SPY423.44+0.33 0.08%
DIA339.31-0.15 -0.04%
IXIC14,292.04+38.77 0.27%

BRIEF-Shanghai Pharma Says Yunnan Baiyao Becomes Its Strategic Investor After A-share Sale

05/11/2021 08:35
BRIEF-Shanghai Pharma Says Yunnan Baiyao Becomes Its Strategic Investor After A-share Sale

- Shanghai Pharmaceuticals Holding Co Ltd 601607.SS:

  • SAYS IT AIMS TO RAISE UP TO 14.4 BILLION YUAN ($2.24 billion) IN A-SHARE PRIVATE PLACEMENT TO BOOST WORKING CAPITAL, REPAY DEBTS

  • SAYS SHANGHAI-BASED BUSINESS CONSULTING FIRM, YUNNAN BAIYAO GROUP CO LTD 000538.SZ WILL SUBSCRIBE TO CO'S SHARE SALES BY CASH

  • SAYS ITS CONTROLLING SHAREHOLDER, ACTUAL OWNER WILL NOT CHANGE AFTER THE SHARE SALE

  • SAYS YUNNAN BAIYAO BECOMES ITS STRATEGIC INVESTOR

Source text in Chinese: https://bit.ly/3y3qwh9 ; https://bit.ly/3oeDODa

Further company coverage: 601607.SS


($1 = 6.4250 Chinese yuan renminbi)


(Reporting by Hong Kong newsroom)

(([email protected]; 852-39525805;))